Tofacitinib in combination with conventional disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: Patient-reported outcomes from a phase III randomized controlled trial - Strand, V; Kremer, J M; Gruben, D (Arthritis Care Res (Hoboken), 2017)
et al.